123 related articles for article (PubMed ID: 7830081)
21. High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors.
Arbilla S; Allen J; Wick A; Langer SZ
Eur J Pharmacol; 1986 Nov; 130(3):257-63. PubMed ID: 2878820
[TBL] [Abstract][Full Text] [Related]
22. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Araujo F; Ruano D; Vitorica J
J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
[TBL] [Abstract][Full Text] [Related]
23. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Benavides J; Peny B; Durand A; Arbilla S; Scatton B
J Pharmacol Exp Ther; 1992 Nov; 263(2):884-96. PubMed ID: 1331419
[TBL] [Abstract][Full Text] [Related]
24. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
Dean B; Scarr E; McLeod M
Brain Res Mol Brain Res; 2005 Aug; 138(2):145-55. PubMed ID: 15950312
[TBL] [Abstract][Full Text] [Related]
25. Rapid down-regulation of [3H]zolpidem binding to rat brain benzodiazepine receptors during flurazepam treatment.
Wu Y; Rosenberg HC; Chiu TH
Eur J Pharmacol; 1995 May; 278(2):125-32. PubMed ID: 7671997
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of GABAergic transmission by zolpidem, an imidazopyridine with preferential affinity for type I benzodiazepine receptors.
Biggio G; Concas A; Corda MG; Serra M
Eur J Pharmacol; 1989 Feb; 161(2-3):173-80. PubMed ID: 2542044
[TBL] [Abstract][Full Text] [Related]
27. A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.
McCabe RT; Wamsley JK; Yezuita JP; Olsen RW
Synapse; 1988; 2(2):163-73. PubMed ID: 2844001
[TBL] [Abstract][Full Text] [Related]
28. Autoradiographic changes in central benzodiazepine binding sites and their coupling to gamma-aminobutyric acid receptors after seizures in the developing rat.
Werck MC; Daval JL
Pediatr Res; 1991 Jul; 30(1):100-5. PubMed ID: 1653933
[TBL] [Abstract][Full Text] [Related]
29. The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration.
Benavides J; Capdeville C; Dauphin F; Dubois A; Duverger D; Fage D; Gotti B; MacKenzie ET; Scatton B
Brain Res; 1990 Jul; 522(2):275-89. PubMed ID: 2171717
[TBL] [Abstract][Full Text] [Related]
30. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.
Benavides J; Peny B; Dubois A; Perrault G; Morel E; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1988 Jun; 245(3):1033-41. PubMed ID: 2838599
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS.
Mehta AK; Shank RP
Brain Res; 1995 Dec; 704(2):289-97. PubMed ID: 8788925
[TBL] [Abstract][Full Text] [Related]
32. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.
Olsen RW; McCabe RT; Wamsley JK
J Chem Neuroanat; 1990; 3(1):59-76. PubMed ID: 2156526
[TBL] [Abstract][Full Text] [Related]
33. The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding.
Nazar M; Siemiatkowski M; Bidziński A; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
J Neural Transm (Vienna); 1999; 106(5-6):355-68. PubMed ID: 10443543
[TBL] [Abstract][Full Text] [Related]
34. Differences in enhancing effects of zolpidem and benzodiazepine drugs on recurrent inhibition in rat hippocampal slices.
Higashima M; Kinoshita H; Yamaguchi N; Koshino Y
Psychopharmacology (Berl); 1997 Jun; 131(4):394-8. PubMed ID: 9226742
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Sanna E; Busonero F; Talani G; Carta M; Massa F; Peis M; Maciocco E; Biggio G
Eur J Pharmacol; 2002 Sep; 451(2):103-10. PubMed ID: 12231378
[TBL] [Abstract][Full Text] [Related]
36. Changes in [3H]-PK 11195 and [3H]-8-OH-DPAT binding following forebrain ischaemia in the gerbil.
Kenny BA; MacKinnon AC; Spedding M; Brown CM
Br J Pharmacol; 1993 Jun; 109(2):437-42. PubMed ID: 8395288
[TBL] [Abstract][Full Text] [Related]
37. Aging-related subunit expression changes of the GABAA receptor in the rat hippocampus.
Gutiérrez A; Khan ZU; Ruano D; Miralles CP; Vitorica J; De Blas AL
Neuroscience; 1996 Sep; 74(2):341-8. PubMed ID: 8865187
[TBL] [Abstract][Full Text] [Related]
38. Effects of chronic ethanol administration on [3H]zolpidem binding in rat brain.
Devaud LL; Morrow AL
Eur J Pharmacol; 1994 Apr; 267(2):243-7. PubMed ID: 8050485
[TBL] [Abstract][Full Text] [Related]
39. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.
Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER
Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065
[TBL] [Abstract][Full Text] [Related]
40. The effects of zolpidem treatment on GABA(A) receptors in cultured cerebellar granule cells: changes in functional coupling.
Vlainić J; Švob Štrac D; Jazvinšćak Jembrek M; Vlainić T; Peričić D
Life Sci; 2012 Jun; 90(23-24):889-94. PubMed ID: 22564411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
